Major Rating Factors:
Good overall results on stability tests (5.8 on a scale of 0 to 10) despite negative cash flow from operations for 2024. Stability strengths include excellent operational trends and good risk diversification. Strong long-term capitalization index (8.2) based on excellent current risk adjusted capital (severe and moderate loss scenarios), despite some fluctuation in capital levels. Ample reserve history (8.3) that helps to protect the company against sharp claims increases.
Other Rating Factors:
Excellent liquidity (7.4) with ample operational cash flow and liquid investments. Fair profitability index (4.3) with operating losses during 2022, 2023 and the first six months of 2025. Return on equity has been low, averaging 1.0% over the past five years.
Stability Factors:
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (98.9%), personal/comm auto (1.1%)
Licensed in:
HI
Principal Investments:
Investment grade bonds (65.6%), common stock (26.8%), cash (7.2%), non investment grade bonds (0.2%), other (0.2%)
Ratios
Premium to Surplus
Reserve to Surplus
1-Year Reserve Development
2-Year Reserve Development
Expense Ratio
Combined Ratio
Cash From Underwriting
Net Premium Growth
Investments in Affiliates
--
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
733 Bishop Street
Honolulu, HI 96813
Honolulu, HI 96813
Phone Number
(808) 535-0511
NAIC Number
10080
Website
--
Largest Affiliates
No affiliate information available.